Table of Contents

September 1, 2022; Volume 50,Issue 3

  1. Rieter, William J.

    1. Risk of Radiation Exposure to Clinical Staff from Paracenteses of Large-Volume Chylous Ascites After <sup>177</sup>Lu-DOTATATE Infusion
      Risk of Radiation Exposure to Clinical Staff from Paracenteses of Large-Volume Chylous Ascites After 177Lu-DOTATATE Infusion
      Sameer Tipnis, William J. Rieter, Vladimir Henderson-Suite and Leonie Gordon
      Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 274-277; DOI: https://doi.org/10.2967/jnmt.121.262820

  2. Robertson, Matthew

    1. 223Ra-Dichloride Therapy
      Sarah Clements, Daniel Tempesta and Matthew Robertson
      Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 222-223; DOI: https://doi.org/10.2967/jnmt.122.264765

  3. Savir-baruch, Bital

    1. 177Lu-PSMA Therapy
      Ephraim E. Parent, Bital Savir-Baruch, Isis W. Gayed, Frankis Almaguel, Bennett B. Chin, Austin R. Pantel, Evan Armstrong, Amanda Morley, Robin C. Ippisch and Robert R. Flavell
      Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 205-212; DOI: https://doi.org/10.2967/jnmt.122.263814

  4. Singh, Baljinder

    1. <sup>68</sup>Ga-Pentixafor PET/CT Demonstrating In Vivo CXCR4 Receptor Overexpression in Rare Lung Malignancies: Correlation with Histologic and Histochemical Findings
      68Ga-Pentixafor PET/CT Demonstrating In Vivo CXCR4 Receptor Overexpression in Rare Lung Malignancies: Correlation with Histologic and Histochemical Findings
      Ankit Watts, Baljinder Singh, Harmandeep Singh, Harneet Kaur, Amanjit Bal, Mehak Vohra, Sunil K. Arora and D. Behera
      Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 278-281; DOI: https://doi.org/10.2967/jnmt.122.264141

  5. Singh, Harmandeep

    1. <sup>68</sup>Ga-Pentixafor PET/CT Demonstrating In Vivo CXCR4 Receptor Overexpression in Rare Lung Malignancies: Correlation with Histologic and Histochemical Findings
      68Ga-Pentixafor PET/CT Demonstrating In Vivo CXCR4 Receptor Overexpression in Rare Lung Malignancies: Correlation with Histologic and Histochemical Findings
      Ankit Watts, Baljinder Singh, Harmandeep Singh, Harneet Kaur, Amanjit Bal, Mehak Vohra, Sunil K. Arora and D. Behera
      Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 278-281; DOI: https://doi.org/10.2967/jnmt.122.264141

  6. Sivaratnam, Dinesh

    1. Indirect Lung Absorbed Dose Verification by <sup>90</sup>Y PET/CT and Complete Lung Protection by Hepatic Vein Balloon Occlusion: Proof of Concept
      Indirect Lung Absorbed Dose Verification by 90Y PET/CT and Complete Lung Protection by Hepatic Vein Balloon Occlusion: Proof of Concept
      Yung Hsiang Kao, Calvin Gan, Alicia Corlett, Alexander Rhodes, Dinesh Sivaratnam and Beng Ghee Lim
      Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 240-243; DOI: https://doi.org/10.2967/jnmt.121.263422

  7. Sood, Apurva

    1. Radioiodine Therapy in Patient with Differentiated Thyroid Cancer and End-Stage Renal Disease on Maintenance Hemodialysis: Case Report with Review of Literature
      Radioiodine Therapy in Patient with Differentiated Thyroid Cancer and End-Stage Renal Disease on Maintenance Hemodialysis: Case Report with Review of Literature
      Munish Kumar, Karthikeyan Subramanian, Karan Singh Tanwar, Arun Prabhahar, Smita Divyaveer, Ashwani Sood, Bhagwant Rai Mittal and Apurva Sood
      Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 228-232; DOI: https://doi.org/10.2967/jnmt.121.261979

  8. Sood, Ashwani

    1. Radioiodine Therapy in Patient with Differentiated Thyroid Cancer and End-Stage Renal Disease on Maintenance Hemodialysis: Case Report with Review of Literature
      Radioiodine Therapy in Patient with Differentiated Thyroid Cancer and End-Stage Renal Disease on Maintenance Hemodialysis: Case Report with Review of Literature
      Munish Kumar, Karthikeyan Subramanian, Karan Singh Tanwar, Arun Prabhahar, Smita Divyaveer, Ashwani Sood, Bhagwant Rai Mittal and Apurva Sood
      Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 228-232; DOI: https://doi.org/10.2967/jnmt.121.261979

  9. Soulek, Diane K.

    1. Practical Considerations for Implementation of 177Lu-DOTATATE Neuroendocrine Tumor Treatment Programs
      Diane K. Soulek, Molly E. Martin, Nic J. Mastascusa and Stephen A. Graves
      Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 195-202; DOI: https://doi.org/10.2967/jnmt.122.263813

  10. Subramanian, Karthikeyan

    1. Radioiodine Therapy in Patient with Differentiated Thyroid Cancer and End-Stage Renal Disease on Maintenance Hemodialysis: Case Report with Review of Literature
      Radioiodine Therapy in Patient with Differentiated Thyroid Cancer and End-Stage Renal Disease on Maintenance Hemodialysis: Case Report with Review of Literature
      Munish Kumar, Karthikeyan Subramanian, Karan Singh Tanwar, Arun Prabhahar, Smita Divyaveer, Ashwani Sood, Bhagwant Rai Mittal and Apurva Sood
      Journal of Nuclear Medicine Technology September 1, 2022, 50 (3) 228-232; DOI: https://doi.org/10.2967/jnmt.121.261979
« Previous (Pages : 6 7 8 9 10 11 ... 11) Next »
Back to top

In this issue